Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
InxMed
company
About
InxMed is a clinical-stage biotech company dedicated to developing innovative, individualized medicines with international impact.
- Shanghai,Shanghai,China
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $50M
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- InxMed (Shanghai) Co., Ltd.
InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equipped with global-level top-notch know-how and efficient execution capabilities.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$75M ¥130M
InxMed has raised a total of
$75M ¥130M
in funding over 2 rounds. Their latest funding was raised on
Jul 21, 2022 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 21, 2022 | Debt Financing | $10M | 1 |
SPD Silicon Valley Bank (SSVB)
|
— | Detail |
| May 8, 2022 | Series B | $15M | 1 |
Hyfinity Investments
|
— | Detail |
| Mar 3, 2022 | Series B | $50M | 4 |
CS Capital
|
— | Detail |
| Sep 4, 2020 | Series A | ¥130M | 4 |
China Growth Capital | CGC
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
5
9
InxMed is funded by 9 investors.
SPD Silicon Valley Bank (SSVB)
and Hyfinity Investments
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
SPD Silicon Valley Bank (SSVB)
|
Yes | Debt Financing |
|
Hyfinity Investments
|
Yes | Series B |
|
CS Capital
|
Yes | Series B |
|
China Growth Capital | CGC
|
Yes | Series A |
|
|
— | Series B |
|
|
— | Series B |
HosenCare Brothers
|
— | Series B |
Grand Yangtze Capital
|
— | Series A |
|
|
— | Series A |
Employee Profiles
Number of Employee Profiles
4
InxMed has 4 current employee profiles, including
Board member Michael Keyoung
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
